T-cell Lymphoproliferative Disorders
📧 Sign up to get email alerts when something new happens for T-cell Lymphoproliferative Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms [Phase 2]
Phase 2 clinical trial update indicating pacritinib is being studied for relapsed/refractory T-cell lymphoproliferative disorders and is cur…